Literature DB >> 22340261

The growing clinical importance of secondary tricuspid regurgitation.

Maurizio Taramasso1, Hugo Vanermen, Francesco Maisano, Andrea Guidotti, Giovanni La Canna, Ottavio Alfieri.   

Abstract

Functional or secondary tricuspid regurgitation (STR) is the most frequent etiology of tricuspid valve pathology in Western countries. Surgical tricuspid repair has been avoided for years, because of the misconception that tricuspid regurgitation should disappear once the primary left-sided problem is treated; this results in a large number of untreated patients with STR. Over the past few years, many investigators have reported evidence in favor of a more aggressive surgical approach to STR. Consequently, interest has been growing in the physiopathology and treatment of STR. The purpose of this review is to explore the anatomical basis, pathophysiology, therapeutic approach, and future perspectives with regard to the management of STR.
© 2012 American College of Cardiology Foundation.

Entities:  

Mesh:

Year:  2012        PMID: 22340261     DOI: 10.1016/j.jacc.2011.09.069

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  41 in total

1.  A detailed mechanical and microstructural analysis of ovine tricuspid valve leaflets.

Authors:  William D Meador; Mrudang Mathur; Gabriella P Sugerman; Tomasz Jazwiec; Marcin Malinowski; Matthew R Bersi; Tomasz A Timek; Manuel K Rausch
Journal:  Acta Biomater       Date:  2019-11-22       Impact factor: 8.947

Review 2.  Surgical indication for functional tricuspid regurgitation at initial operation: judging from long term outcomes.

Authors:  Alberto Pozzoli; Elisabetta Lapenna; Luca Vicentini; Ottavio Alfieri; Michele De Bonis
Journal:  Gen Thorac Cardiovasc Surg       Date:  2016-06-21

Review 3.  [Hemodynamic interplay between tricuspid valve and right ventricle].

Authors:  C Edel; R Erbel; T Budde
Journal:  Herz       Date:  2017-11       Impact factor: 1.443

4.  Current transcatheter devices to treat functional tricuspid regurgitation with discussion of issues relevant to clinical trial design.

Authors:  Rebecca T Hahn
Journal:  Ann Cardiothorac Surg       Date:  2017-05

Review 5.  Cardiac Computed Tomography (CT) Evaluation of Valvular Heart Disease in Transcatheter Interventions.

Authors:  Marcelo Godoy; Ahmed Mugharbil; Malcom Anastasius; Jonathon Leipsic
Journal:  Curr Cardiol Rep       Date:  2019-11-25       Impact factor: 2.931

6.  Mitral valve restenosis after closed mitral commissurotomy: case discussion.

Authors:  Anyi Xu; Jiang Jin; Xiaodong Li; Jian Xiao; Peng Zhu; Wenhui Gong; Yue Liu; Yuetian Yu; Chunguang Wang; Chengxin Zhang; Irbaz Hameed; Arash Salemi; Daniel Hernandez-Vaquero; Taufiek Konrad Rajab; Francesco Nappi; Jianfei Shen; Baofu Chen
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

7.  Transcatheter Treatment of Functional Tricuspid Regurgitation Using the Trialign Device.

Authors:  Christian Besler; Christopher U Meduri; Philipp Lurz
Journal:  Interv Cardiol       Date:  2018-01

Review 8.  Pathophysiology and management of multivalvular disease.

Authors:  Philippe Unger; Marie-Annick Clavel; Brian R Lindman; Patrick Mathieu; Philippe Pibarot
Journal:  Nat Rev Cardiol       Date:  2016-04-28       Impact factor: 32.419

9.  Management of Tricuspid Regurgitation: The Role of Transcatheter Therapies.

Authors:  Maurizio Taramasso; Christelle Calen; Andrea Guidotti; Shingo Kuwata; Hector Rodriguez Cetina Biefer; Fabian Nietlispach; Michel Zuber; Francesco Maisano
Journal:  Interv Cardiol       Date:  2017-05

10.  Severity of tricuspid regurgitation is associated with long-term mortality.

Authors:  Brian J Kelly; Jamahal Maeng Ho Luxford; Carolyn Goldberg Butler; Chuan-Chin Huang; Kerry Wilusz; Julius I Ejiofor; James D Rawn; John A Fox; Stanton K Shernan; Jochen Daniel Muehlschlegel
Journal:  J Thorac Cardiovasc Surg       Date:  2017-11-08       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.